SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
serial mean |
141.7 |
mmHg |
7.4 |
26.68 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
0 |
|
|
69536 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
serial mean |
159.0 |
mmHg |
6.4 |
23.08 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
0 |
|
|
69538 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
20 |
serial mean |
135.6 |
mmHg |
3.2 |
14.31 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
0 |
|
|
69539 |
151 |
BN.GH-(D18Rat41-D18Mgh4)/Mcwi |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
11 |
|
-1.25 |
(beats/min)/(ug/kg) |
0.05 |
0.17 |
vascular indwelling catheter method |
|
0.0 |
0 |
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
138469 |
101 |
BN/NHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
19 |
serial mean |
22.0 |
mmHg |
3.0 |
13.08 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
0 |
|
|
67301 |
151 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (0.5 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
serial mean |
120.4 |
mmHg |
5.3 |
24.29 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
0 |
|
|
69535 |
151 |
SS/JrHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
serial mean |
168.4 |
mmHg |
7.0 |
25.24 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
0 |
|
|
69540 |
151 |
BN/Elh |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
14 |
|
-2.28 |
(beats/min)/(ug/kg) |
0.07 |
0.26 |
vascular indwelling catheter method |
|
0.0 |
0 |
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
138470 |
101 |
SS/JrHsdMcwi |
absolute change in mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (3 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
13 |
serial mean |
39.0 |
mmHg |
6.0 |
21.63 |
vascular indwelling catheter method |
left femoral artery |
0.0 |
0 |
|
|
67302 |
151 |
GH/Omr |
change in heart rate to change in vasoactive chemical dose ratio |
angiotensin II (5-50 ng/kg/min) (between 0.2 and 1 hours) then norepinephrine (0.1-1 ug/kg/min) (between 0.2 and 1 hours) then phenylephrine (4 ug/kg) (between 0 and 0 hours) |
Bilusic M, et al., Croat Med J. 2008 Oct;49(5):586-99. |
heart pumping trait |
male |
132 days-146 days |
14 |
|
-0.87 |
(beats/min)/(ug/kg) |
0.07 |
0.25 |
vascular indwelling catheter method |
|
0.0 |
0 |
ng/kg/min |
change in heart rate to change in vasoactive chemical dose ratio (CMO:0003904), (beats/min)/(ug/kg) |
138468 |
101 |
BN/NHsdMcwi |
mean arterial blood pressure |
furosemide (10 mg/kg) then controlled sodium content diet (0.4 %) (for 7 days) then norepinephrine (1 ug/kg/min) (for 0.1 hours) |
Moreno C, et al., Physiol Genomics 2003 Nov 11;15(3):243-57. |
arterial blood pressure trait |
female |
101 days-103 days |
21 |
serial mean |
128.6 |
mmHg |
4.0 |
18.33 |
vascular indwelling catheter method |
left femoral artery |
120.0 |
0 |
|
|
69537 |
151 |